KUC 7483 CL
Sponsors
Boehringer Ingelheim
Conditions
HealthySpinal Cord Injuries
Phase 1
In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male Subjects
CompletedNCT02256722
Start: 2005-10-31Updated: 2014-10-06
Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers
CompletedNCT02259933
Start: 2004-02-29Updated: 2014-10-09
Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity
CompletedNCT02259751
Start: 2004-02-29Updated: 2014-10-09
Safety, Tolerability and Pharmacokinetics of KUC 7483 Tablets in Healthy Male Volunteers
CompletedNCT02259907
Start: 2003-05-31Updated: 2014-10-09